154 related articles for article (PubMed ID: 27178711)
1. Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study.
Aben KK; Osanto S; Hulsbergen-van de Kaa CA; Soetekouw PM; Stemkens D; Bex A
World J Urol; 2016 Aug; 34(8):1053-60. PubMed ID: 27178711
[TBL] [Abstract][Full Text] [Related]
2. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
3. Variation in the management of cT1 renal cancer by surgical hospital volume: A nationwide study.
Yildirim H; Schuurman MS; Widdershoven CV; Lagerveld BW; van den Brink L; Ruiter AEC; Beerlage HP; van Moorselaar RJA; Graafland NM; Bex A; Aben KKH; Zondervan PJ
BJUI Compass; 2023 Jul; 4(4):455-463. PubMed ID: 37334025
[TBL] [Abstract][Full Text] [Related]
4. Practice patterns for the surgical treatment of T1 renal cell carcinoma: a nationwide population-based register study.
Ljungberg B; Gudmundsson E; Christensen S; Lundstam S;
Scand J Urol; 2014 Oct; 48(5):445-52. PubMed ID: 24666103
[TBL] [Abstract][Full Text] [Related]
5. Guideline adherence for the surgical treatment of T1 renal tumours correlates with hospital volume: an analysis from the British Association of Urological Surgeons Nephrectomy Audit.
Tran MGB; Aben KKH; Werkhoven E; Neves JB; Fowler S; Sullivan M; Stewart GD; Challacombe B; Mahrous A; Patki P; Mumtaz F; Barod R; Bex A;
BJU Int; 2020 Jan; 125(1):73-81. PubMed ID: 31293036
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses.
Liss MA; Wang S; Palazzi K; Jabaji R; Patel N; Lee HJ; Parsons JK; Derweesh IH
BMC Urol; 2014 Dec; 14():101. PubMed ID: 25519922
[TBL] [Abstract][Full Text] [Related]
7. National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival.
Hjelle KM; Johannesen TB; Bostad L; Reisæter LAR; Beisland C
Eur Urol Oncol; 2018 Aug; 1(3):252-261. PubMed ID: 31102628
[TBL] [Abstract][Full Text] [Related]
8. Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi-institutional study.
Antonelli A; Ficarra V; Bertini R; Carini M; Carmignani G; Corti S; Longo N; Martorana G; Minervini A; Mirone V; Novara G; Serni S; Simeone C; Simonato A; Siracusano S; Volpe A; Zattoni F; Cunico SC;
BJU Int; 2012 Apr; 109(7):1013-8. PubMed ID: 21883829
[TBL] [Abstract][Full Text] [Related]
9. Cost comparison of nephron-sparing treatments for cT1a renal masses.
Castle SM; Gorbatiy V; Avallone MA; Eldefrawy A; Caulton DE; Leveillee RJ
Urol Oncol; 2013 Oct; 31(7):1327-32. PubMed ID: 22361086
[TBL] [Abstract][Full Text] [Related]
10. Evolving practice patterns for the management of small renal masses in the USA.
Yang G; Villalta JD; Meng MV; Whitson JM
BJU Int; 2012 Oct; 110(8):1156-61. PubMed ID: 22372984
[TBL] [Abstract][Full Text] [Related]
11. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
12. Trends in the surgical management of localized renal masses: thermal ablation, partial and radical nephrectomy in the USA, 1998-2008.
Woldrich JM; Palazzi K; Stroup SP; Sur RL; Parsons JK; Chang D; Derweesh IH
BJU Int; 2013 Jun; 111(8):1261-8. PubMed ID: 23470140
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the RENAL nephrometry scoring system in adopting nephron-sparing surgery for cT1 renal cancer.
Yasuda Y; Yuasa T; Yamamoto S; Urakami S; Ito M; Sukegawa G; Kitsukawa S; Yonese J; Fukui I
Urol Int; 2013; 90(2):179-83. PubMed ID: 23146865
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
[TBL] [Abstract][Full Text] [Related]
15. A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor.
Cost NG; Sawicz-Birkowska K; Kajbafzadeh AM; Tourchi A; Parigi GB; Guillén G; DeFoor WR; Apoznanski W
Urology; 2014 Jun; 83(6):1388-93. PubMed ID: 24768019
[TBL] [Abstract][Full Text] [Related]
16. Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
von Klot C; Herrmann TR; Wegener G; Kuczyk MA; Hupe MC; Akkoyun M; Peters I; Kramer MW; Merseburger AS
Adv Ther; 2013 Oct; 30(10):924-32. PubMed ID: 24155056
[TBL] [Abstract][Full Text] [Related]
17. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
[TBL] [Abstract][Full Text] [Related]
18. Utilization and quality outcomes of cT1a, cT1b and cT2a partial nephrectomy: analysis of the national cancer database.
Fero K; Hamilton ZA; Bindayi A; Murphy JD; Derweesh IH
BJU Int; 2018 Apr; 121(4):565-574. PubMed ID: 29032581
[TBL] [Abstract][Full Text] [Related]
19. A Statewide Quality Improvement Collaborative's Adherence to the 2017 American Urological Association Guidelines Regarding Initial Evaluation of Patients With Clinical T1 Renal Masses.
Ginsburg KB; Johnson K; Moldovan T; Peabody H; Qi J; Dunn RL; Rogers C; Weizer A; Kaul S; Johnson A; Traver M; Lane BR;
Urology; 2021 Dec; 158():117-124. PubMed ID: 34499969
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
